Treatment decisions in estrogen receptor-positive early breast cancer patients with intermediate oncotype DX recurrence score results

This retrospective study evaluated the impact of intermediate Recurrence Score(®) results on adjuvant treatment decisions in estrogen receptor-positive (ER+) early invasive breast cancer, comparing treatment recommendations pre-testing with actual treatments received post-testing. Of the 111 patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Fried, Georgeta, Moskovitz, Mor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925494/
https://www.ncbi.nlm.nih.gov/pubmed/24567880
http://dx.doi.org/10.1186/2193-1801-3-71

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925494/
https://www.ncbi.nlm.nih.gov/pubmed/24567880
http://dx.doi.org/10.1186/2193-1801-3-71

Ejemplares similares